Cite
HARVARD Citation
Castañón, E. et al. (2021). Erratum to "Critical reappraisal of phase III trials with immune checkpoint inhibitors in non-proportional hazards settings" [Eur J Cancer 136 (September 2020) 159−168]. European journal of cancer. pp. 152-153. [Online].